Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

174 Mon, 7/30/2018, 10:30 AM - 12:20 PM CC-West 210
Biomarkers and Endpoint Validation — Contributed Papers
Biopharmaceutical Section
Chair(s): Veronica Powell, QST Consultations
10:35 AM Leveraging Omics Biomarker in Early Clinical Trials - Concept, Utility and Impact on Decision Making

Weidong Zhang, Pfizer Inc.
10:50 AM Inference on Treatment Effect Modification by Marker Response in a Baseline Surrogate Measure Three-Phase Sampling Design
Michal Juraska, Fred Hutchinson Cancer Research Center; Ying Huang, Fred Hutchinson Cancer Research Center; Peter Gilbert, Fred Hutchinson Cancer Research Center
11:05 AM Comparison of Methods to Generate Reference Limits
Bipasa Biswas, CDRH, FDA; Nairita Ghosal, University of Illinois at Chicago
11:20 AM An Analysis of MIMIC Data for Potential Surrogate Markers for Vaccine Development

Robert Small, Sanofi Pasteur; Pauline Jurvilliers, Sanofi Pasteur
11:35 AM Statistics Used in Assay Validation
Kenneth Liu
11:50 AM Longitudinal Models for Kidney Function Decline

Jing Zhang, Moores UCSD Cancer Center; Loki Natarajan, UCSD; Kumar Sharma, Division of Nephrology,University of Texas Health San Antonio; Tina Costacou, University of Pittsburgh; Janet Snell-Bergeon , University of Colorado Anschutz Medical Campus, School of Medicine; Rachel Miller, University of Pittsburgh; Trevor Orchard, University of Pittsburgh
12:05 PM Floor Discussion